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Background: We investigated the whole genome sequence (WGS) of a carbapenem-resis-
tant Acinetobacter baumannii isolate belonging to the global clone 2 (GC2) and predicted 
resistance islands using a software tool.
Methods: A. baumannii strain YU-R612 was isolated from the sputum of a 61-yr-old man 
with sepsis. The WGS of the YU-R612 strain was obtained by using the PacBio RS II Se-
quencing System (Pacific Biosciences Inc., USA). Antimicrobial resistance genes and re-
sistance islands were analyzed by using ResFinder and Genomic Island Prediction soft-
ware (GIPSy), respectively.
Results: The YU-R612 genome consisted of a circular chromosome (ca. 4,075 kb) and 
two plasmids (ca. 74 kb and 5 kb). Its sequence type (ST) under the Oxford scheme was 
ST191, consistent with assignment to GC2. ResFinder analysis showed that YU-R612 pos-
sessed the following resistance genes: four β-lactamase genes blaADC-30, blaOXA-66, blaOXA-23, 
and blaTEM-1; armA, aadA1, and aacA4 as aminoglycoside resistance-encoding genes; 
aac(6’)Ib-cr for fluoroquinolone resistance; msr(E) for macrolide, lincosamide, and strepto-
gramin B resistance; catB8 for phenicol resistance; and sul1 for sulfonamide resistance. 
By GIPSy analysis, six putative resistant islands (PRIs) were determined on the YU-R612 
chromosome. Among them, PRI1 possessed two copies of Tn2009 carrying blaOXA-23, and 
PRI5 carried two copies of a class I integron carrying sul1 and armA genes.
Conclusions: By prediction of resistance islands in the carbapenem-resistant A. bauman-
nii YU-R612 GC2 strain isolated in Korea, PRIs were detected on the chromosome that 
possessed Tn2009 and class I integrons. The prediction of resistance islands using soft-
ware tools was useful for analysis of the WGS. 
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INTRODUCTION
Acinetobacter baumannii is an opportunistic pathogen that 
causes hospital-acquired infections, especially in intensive care 
units [1-3]. The incidence and worldwide dissemination of car-
bapenem-resistant A. baumannii isolates named global clone 
(GC)1 and GC2 have increased [4-6]. Carbapenem resistance 
in A. baumannii has mainly been ascribed to degradation by 
carbapenem-hydrolyzing oxacillinases including OXA-23, OXA-
24, OXA-58, OXA-51, OXA-143, and their variants [2, 7].
Large DNA sequences (6-200 kb) are termed genomic is-
lands when they are acquired from other organisms through 
plasmids, transposons, and other mobile genetic elements [8, 
9]. Among the genomic islands of A. baumannii, multiple antibi-
Lee Y, et al.
Putative resistance islands of A. baumannii
http://dx.doi.org/10.3343/alm.2016.36.4.320 www.annlabmed.org  321
otic resistance regions that have inserted into the target ATPase 
gene (comM) are termed resistance islands (AbaR) [10]. There 
are several known AbaRs, which differ according to the clone 
type [11, 12]. The AbaR3-type resistance islands are the major 
resistance islands of GC1 isolates, and the AbaR4-type islands 
are associated with GC2 isolates [13-15]. Some AbaR4-type is-
lands of A. baumannii harbor transposons such as Tn2009, 
Tn2006, and Tn6008 carrying the blaOXA-23 gene [16].
Because in vitro approaches to investigate genomic islands 
are time-consuming and expensive, several software tools for 
identifying putative genomic islands have been developed. 
Some useful software tools and resources for identification of 
antimicrobial resistance genes have also been reported, such as 
ResFinder from the Center for Genomic Epidemiology and the 
Comprehensive Antibiotic Research Database (CARD) [17, 18]. 
Recently, an island prediction software tool (Genomic Island 
Prediction software [GIPSy]) was introduced for the prediction 
of genomic islands in bacteria [9]. Here, we investigated the 
whole genome sequence (WGS) of a carbapenem-resistant A. 
baumannii isolate belonging to GC2 and predicted the resis-
tance islands using software tools.
METHODS
1. Bacterial strains and antimicrobial susceptibility tests
The A. baumannii YU-R612 strain was isolated from the spu-
tum of a 61-yr-old man with sepsis in Severance Hospital, 
Seoul, Korea. The species was identified by conventional meth-
ods and the VITEK 32 GN system (bioMérieux, Marcy l’Etoile, 
France). Antimicrobial susceptibility testing was performed by 
using the VITEK II N211 system (bioMérieux). The YU-R612 
strain was resistant to multiple antibiotics including piperacillin 
(minimum inhibitory concentration [MIC] ≥128 μg/mL), ceftazi-
dime (≥64 μg/mL), cefotaxime (≥64 μg/mL), cefepime (≥64 
μg/mL), imipenem (≥16 μg/mL), meropenem (≥16 μg/mL), 
ampicillin/sulbactam (≥32 μg/mL), ciprofloxacin (≥4 μg/mL), 
and gentamicin (≥16 μg/mL); however, it was susceptible to 
minocycline (≤1 μg/mL) and colistin (≤0.5 μg/mL). Modified 
Hodge tests and EDTA plus sodium mercaptoacetic acid (SMA) 
double-potentiation tests were carried out to screen carbapene-
mase and metallo-β-lactamase activity, respectively. Both tests 
showed negative results, which suggested the absence of 
metallo-β-lactamase genes in this strain.
2. Whole genome sequencing and PCR experiments
The WGS of the YU-R612 strain was obtained by using the 
PacBio RS II sequencing system (Pacific Biosciences Inc. Menlo 
Park, CA, USA) in a commercial laboratory (Macrogen, Seoul, 
Korea). PCR was performed by using in-house primers (Table 1). 
3. Identification of the resistome and resistance islands
Antimicrobial resistance genes were analyzed by using Res-
Finder, the resources from the Center for Genomic Epidemiol-
ogy (www.genomicepidemiology.org). A ResFinder threshold of 
ID=98% was selected. Genomic islands were determined by 
using resources from Genomic Island Prediction software 
(GIPSy) as previously described [9]. 
RESULTS
The A. baumannii strain YU-R612 genome consisted of a circu-
lar chromosome (ca. 4,075 kb) and two plasmids (ca. 74 kb 
and 5 kb). WGS analysis showed that the sequence type (ST) 
under the Oxford scheme was ST191 (1-3-3-2-2-94-3) and un-
der the Institute Pasteur Multi Locus Sequence Typing (MLST) 
scheme was ST2, which was consistent with the assignment of 
this strain to GC2. ResFinder analysis showed that the YU-R612 
strain possessed the following resistance genes on its chromo-
some: four β-lactamase genes, namely blaADC-30 (identity, 100%), 
blaOXA-66 (100%), blaOXA-23 (100%), and blaTEM-1 (100%); armA 
(100%), aadA1 (100%), and aacA4 (99.6%) as aminoglycoside 
resistance-encoding genes; aac(6’)Ib-cr (99.2%) for fluoroqui-
nolone resistance; msr(E) (100%) for macrolide, lincosamide, 
and streptogramin B resistance; catB8 (100%) for phenicol re-
sistance; and sul1 (100%) for sulfonamide resistance. 
Six putative resistant islands (PRIs) were determined on the 
chromosome of the YU-R612 strain by using the GIPSy tool (Fig. 
1). PRI1 possessed two copies of Tn2009 carrying the blaOXA-23 
gene (Fig. 2A). PRI5 carried two copies of a class I integron in-
cluding 5´ conserved sequence (CS) and 3´CS, and their gene 
Table 1. Nucleotide sequences of primers designed for this study
Primer Sequence 5´-3´
P1 ACCCCTTCATCATCTTCTGCA
P2 TGAACAATCTGACTCGGGGT
P3 GTCAGTTGCACTTGGTCGAA
P4 GGCGTTCTTTGGAGTGGAAG
P5 GGAATCGTTGCTGTTGGTCA
P6 TGCAAAGTTAGCGATGAGGC
P7 TCCAAGAGCAACGTACGACT
P8 GGCCATTGACCTTCACGTAG
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Fig. 1. Circular genome comparison showing putative resistance islands predicted for Acinetobacter baumannii strain YU-R612 by GIPSy. 
The figure was plotted by using A. baumannii AYE strain as a reference and generated by using the Basic Local Alignment Search Tool 
(BLAST) Ring Image Generator (BRIG) software. 
Abbreviations: PRI, putative resistance island; GIPSy, Genomic Island Prediction software. 
Fig. 2. Structures of putative resistance island 1 (A) and putative resistance island 5 (B) identified by using GIPSy and an AbaR4-like resis-
tance island (C) in the YU-R612 strain. The short arrows indicate the primers (P1 to P8).
A
B
C
Putative resistance island 1 (416,461-436,820; 20.4 kb)
Putative resistance island 5 (2,282,260-2,304,128; 21.9 kb)
AbaR4-type-like resistance island (3,985,849-3,996,489; 10.6 kb)
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cassettes possessed sul1 and armA resistance genes (Fig. 2B). 
PRI2, PRI3, PRI4, and PRI6 carried several hypothetical pro-
teins that could not be further annotated. Antimicrobial resis-
tance genes detected by ResFinder were not found on PRI2, 
PRI3, PRI4, or PRI6. 
Interestingly, in addition to the PRIs, a resistance island was 
identified that was inserted in the comM gene on the YU-R612 
chromosome. The resistance island was 10.6 kb in size and 
very similar to AbaR4-type resistance islands, especially 
Tn6022, which consists of the tniC-tniA-tniB-tinE-orf-uspA-sul1 
genes bracketed by a partial comM gene (Fig. 2C). There were 
two plasmids in the YU-R612 strain, which did not harbor PRIs 
or antimicrobial resistance genes.
This draft genome sequencing project has been deposited at 
the GenBank nucleotide database (GenBank nos. CP014215, 
CP014216, and CP014217) under BioProject ID PRJNA309091.
DISCUSSION
Strain YU-R612 is a multiple antibiotic-resistant isolate recov-
ered from a patient with pneumonia. Resistance to multiple an-
tibiotics correlated with the presence of antimicrobial resistance 
genes detected by ResFinder: blaOXA-23 for resistance to imipe-
nem and meropenem, armA for gentamicin, and aac(6’)Ib-cr 
for ciprofloxacin, which are major resistance genes for A. bau-
mannii in Korea [19, 20]. 
Under the Oxford scheme, the YU-R612 strain was shown to 
be ST191, indicating that it is a member of the GC2, which ac-
counts for the majority of isolates recovered in Korea [19]. GC2, 
which includes clonal complex 92 in the MLST Oxford scheme, 
has also been identified among carbapenem-resistant A. bau-
mannii strains in Asian and European countries [19]. Among 
the resistance islands of A. baumannii, AbaR4-type resistance 
islands are common in GC2 isolates [12]. Clonal dissemination 
and diversification of GC92 and the predominance of AbaR4-
type resistance islands among these isolates have been reported 
in Korea [15].
AbaR4-type islands that shared a core structure similar to 
AbaR4 appeared to be distributed in GC2 isolates via integration 
into a distinct genomic site at comM. The backbone of AbaR4 
comprised five open reading frames constituting the so-called 
transposition module with two other genes encoding the univer-
sal stress protein (uspA) and sulfate permease (sul1) [21]. In 
this study, a 10.6-kb AbaR4-type resistance island was detected 
in the YU-R612 strain. While some AbaR4-type resistance is-
lands possess transposons such as Tn2006 and Tn1213 carry-
ing antibiotic resistance genes such as blaOXA-23, the YU-Y612 
strain did not carry any transposons or antibiotic resistance 
genes on its AbaR4-type-like resistance island. However, the bla-
OXA-23 gene on the Tn2009 of YU-R612 strain was detected in 
PRI1.
In this study, six PRIs were identified on the chromosome of 
the YU-R612 strain by using the GIPSy tool. Among them, two 
PRIs (PRI1 and PRI5) possessed transposons and class I inte-
grons that carried important resistance genes: blaOXA-23, armA, 
and sul1. The duplication of Tn2009 in PRI1 and class I inte-
grons in PRI5 was confirmed by using PCR to supplement a 
limitation of deep sequencing for the replication. 
The GIPSy software facilitated the prediction of resistance is-
lands and resistance genes in the WGS of this strain. Although 
some PRIs detected by software tools are different from known 
resistance islands, this software may be useful to identify novel 
genomic islands carrying clusters of resistance genes. Software 
tools provide a convenient way of identifying PRIs as well as ac-
quired antimicrobial resistance genes, and they may simplify 
the complex steps in analyzing the WGS of bacteria in clinical 
microbiology laboratories. 
In conclusion, the prediction of resistance islands in the WGS 
of a carbapenem-resistant A. baumannii strain belonging to 
GC2 in Korea revealed PRIs on the chromosome that carried 
Tn2009 and class I integrons. The predicted resistance islands 
using software tools helped in the analysis of the WGS in this 
strain. 
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